Session 356
#RCT3718
Depemokimab PK/PD in the 52-week randomised double-blind multicentre Phase III SWIFT-1 trial
I. Pavord
Oral presentation
Session 345
#OA3647
Mepolizumab in patients with asthma and features of COPD: a MENSA/MUSCA post hoc analysis
I. Pavord
Poster presentation
Session 415
#PA4492
Mepolizumab response in patients with COPD and an eosinophilic phenotype with/without chronic bronchitis (CB): a METREX/METREO post hoc analysis
C. Vogelmeier
Poster presentation
Session 460
#PA4783
Clinical trial design of biologic therapies in COPD: MATINEE study of mepolizumab
I. Pavord
Poster presentation
Session 460
#PA4789
Real-world assessment of clinical remission in asthma with biologics
P. Howarth
Poster presentation
Session 225
#PA2182
Clinical characteristics impacting clinical remission attainment in REALITI-A
G. Canonica
Poster presentation
Session 133
#PA1200
Assessment of the components of clinical remission with moderate–severe asthma after 24–52 weeks of treatment: CAPTAIN post hoc analysis
I. Pavord
Poster presentation
Session 133
#PA1198
Characteristics of patients meeting the components of clinical remission: CAPTAIN post hoc analysis
S. Noorduyn
Poster presentation
Session 133
#PA1197
Impact of varying lung function threshold on clinical remission in asthma with FF/UMEC/VI: CAPTAIN post hoc analysis
I. Pavord
Poster presentation
Session 133
#PA1199
Towards disease stability in COPD management: patient perspectives
M. Brooke
Poster presentation
Session 132
#PA1171
Impact of varying health status thresholds on disease stability in COPD with FF/UMEC/VI: IMPACT post hoc analysis
D. Halpin
Poster presentation
Session 132
#PA1173
Impact of varying lung function thresholds on disease stability in COPD with FF/UMEC/VI: IMPACT post hoc analysis
D. Halpin
Oral presentation
Session 443
#OA4653
GSK continues to build on decades of pioneering work to deliver more ambitious treatment goals, develop the next generation standard of care, and redefine the future of respiratory medicine for hundreds of millions of people with respiratory diseases. With an industry-leading respiratory portfolio and pipeline of vaccines, targeted biologics and inhaled medicines, we are focused on improving outcomes and the lives of people living with all types of asthma and COPD along with less understood refractory chronic cough or rarer conditions like systemic sclerosis with interstitial lung disease. GSK is harnessing the latest science and technology with the aim to modify underlying disease dysfunction and prevent disease progression.
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.com.
GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described under Item 3.D “Risk factors” in GSK’s Annual Report on Form 20-F for 2023, and GSK’s Q2 Results for 2024.
Access the contact details of our media relations teams at GSK
Search and download images and B-roll video for use in the media.
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together
IMAGES
VIDEO
COMMENTS
Medelis is a full service oncology clinical research company. We provide sponsors with a highly-skilled and proactive oncology clinical trial management team to design and manage phase I through phase III oncology trials in North America and Europe. ... Global Contract Research Organizations in United States. 54gene's Clinical Programs Group ...
1. IQVIA. Formerly known as Quintiles and IMS Health, IQVIA is one of the largest CROs in the world, with a large range of service offerings to help advance clinical research. The company was founded in North Carolina in 1982, and has since grown to over 88,000 employees in more than 100 countries.
Here is a quick overview of the best companies of clinical research: IQVIA: Best for data-driven insights and advanced analytics in healthcare research. ICON: Best for comprehensive clinical development services and therapeutic expertise. Parexel: Best for global biopharmaceutical services, emphasizing regulatory and clinical trial excellence.
Founded: 1982 Headquarters: Waltham, Massachusetts Annual Revenue: $3B Employee Size: 18,000 Parexel is another important name in the list of Clinical Research Companies In USA that specializes on behalf of its pharmaceutical partners in carrying out clinical studies to boost and make certain that the medicine approval process takes place smoothly. It has a wide range of offerings that spreads ...
Who we are. Parexel is among the world's largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help lifesaving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory, and therapeutic expertise, our team of more than 21,000 global professionals ...
Parexel is a clinical research organization that provides biopharmaceutical services and solutions. They have expertise in clinical development, translational medicine, and early phase research. Parexel has over 10,000 employees in 50 countries. Parexel has been recognized by Frost & Sullivan with the 2022 Global Customer Value Leadership Award.
Top 10 Leading Clinical Research Companies In The USA. The landscape of drug discovery and development is intricate, demanding significant resources at each stage of the process. As pharmaceutical companies strive to bring groundbreaking therapies to market, they increasingly rely on the expertise of Contract Research Organizations (CROs).
The top 15 CROs globally would be in the following order based on 2023 revenue: LabCorp (Covance), with 15.05 billion USD (2023) and 75000 employees (Labcorp, 2024). In February 2015, Labcorp completes its $6 billion purchase of Covance, Inc., creating the world's leading health care diagnostics company.
The PPD™ clinical research business of Thermo Fisher Scientific is a global contract research organization (CRO) delivering clinical expertise for your product's success. ... Meet Us at ESMO in Barcelona ... A model intentionally built to serve the needs of small- to mid-sized biotech and pharma companies. Simplify the journey.
ACRO works with US legislators and regulators to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research. ... The Association of Clinical Research Organizations (ACRO) represents the leading clinical research and technology companies around the world. In our newsletter, we bring you updates on our ...
List of clinical research organizations in the US. 1. IQVIA. IQVIA is a globally renowned medical research companies in USA that stands out for its exceptional contributions to the healthcare and pharmaceutical industries. As one of the leading providers of advanced analytics, technology solutions, and contract research services, IQVIA plays a ...
Regulatory Compliance, Drug Safety and Pharmacovigilance. Parexel Biotech provides the end-to-end capabilities you'll need to succeed. We're fast, flexible, and dedicated to impacting patient lives. Utilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and ...
The United States of America has some of the top clinical research organizations in the world. Amongst them, here is the list of the 10 Best Clinical Research Organizations In The USA. 1. Covance. Source. Annual Revenue: $9.6B. Headquarters: Princeton, New Jersey. Number of Employees: 50,000+. Total Funding: $0.
KCR is an international full-service contract research organization providing clinical development solutions for the biotechnology and pharmaceutical industries. ... in both cattle and humans which led to the pasteurization of milk in US in 1930. Evans was the first woman president elected by the Society of American Bacteriologists.
A research services and strategic resourcing organization committed to providing a better clinical experience by delivering comprehensive Contract Research Organization (CRO), Functional Service Provider (FSP) and Strategic Resourcing services that optimize effectiveness for both patients and sponsors throughout the clinical research journey.
Scale for a purpose: Supporting research programs worldwide. From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health. Whether you're ready to conduct a single-site study or a complex, high-volume clinical trial, contact Velocity. Visit the Velocity ...
Worldwide Clinical Trials - Global Contract Research Organization (CRO) Discover how our continuous improvement initiative can benefit your bioanalytical and clinical programs. WorldwideEdge™. 2024 CRO Leadership Awards. Look no further. Personalized attention. Find your place. Clinical research isn't a straight path. Let's navigate it ...
Novum is a full-service CRO with an impeccable performance record and numerous FDA approvals in new drug, 505 (b) (2) and ANDA submissions. We manage complex studies across numerous therapeutic areas and dosage forms, spanning early phase to late phase trials. With the full integration of our bioanalytical unit in Toronto, Canada in 2020, Novum ...
Catalyst Flex is a provider of specialized, multi-therapeutic functional solutions delivered by experts in clinical operations, data management, biostatistics and programming, safety and medical writing. We leverage experienced clinical research professionals to partner and address your study needs. Learn About Catalyst Flex.
Veristat's collaboration was critical to the successful clinical trials that led to our product's approval. Counting on Veristat for the preparation of our New Drug Application (NDA) is the culmination of years of hard work and dedication by the Veristat team. I have truly come to rely on the clinical and statistical expertise of Veristat over ...
PPD (CEO David Simmons) is a leading global CRO founded in 1985, providing comprehensive drug development, laboratory, and lifecycle management services. PPD's central offices are located in Wilmington, North Carolina, and has around 23,000 employees around the world. PPD's annual revenue in 2018 was $2.8 billion.
Contract research organisations (CROs) are companies that are contracted to provide support to pharmaceutical, biotechnology and medical device companies to successfully complete product development. This includes, but is not limited to, clinical trial operation, patient recruitment and the design of protocols.
ICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, ... ICON acquires HumanFirst, a cloud-based technology company for life sciences supporting precision measurement in patient centred clinical research.
7 years of involvement in clinical research or drug development spanning clinical activities in Phases I-IV; 3-5 years of contribution in all aspects of conducting clinical trials - planning, implementing, reporting and publishing. Demonstrated ability to establish strong scientific partnership with key collaborators.
The research, including three late-breaking abstracts, demonstrates the company's commitment and ongoing ambition to redefine the future of respiratory medicine and deliver the next generation standard of care for millions of people affected by respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), refractory ...